Whether you’re ready to request a demo, explore pricing, or ask a question, our team is here to help.

Prefer to talk directly? Call 1 800 720 7504 or email:
Nick Garofoli, our Head of Business Development – US at [email protected]
David Allsopp, Head of Business Development, North America at [email protected]

 

Prefer to talk directly?
Call 1 800 720 7504 or
email Nick Garofoli, our
Head of Business Development – US
at [email protected].

PainChek® meets regulatory standards for use in Australia, New Zealand, Canada, Singapore, Malaysia, the United Kingdom, the European Union, and PainChek® Adult has been granted a De Novo classification by the US Food and Drug Administration (FDA) for its PainChek® Adult App. The FDA De Novo Grant number is DEN240073. The tool is included in the Australian Register of Therapeutic Goods (ARTG) under ARTG number 302794.

PainChek® is a registered trade mark of PainChek in Australia, the United Kingdom, the European Union, and a trade mark in other jurisdictions.

Privacy Preference Center

PainChek
Cookies on the PainChek website

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.